Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-10

Clinical Trial Update: Insulinotropic Effect of GLP-1 and GIP After Dexamethasone [NA]

View source ↗

Summary

A completed trial in individuals with Type 2 diabetes investigated the insulinotropic effects of the incretin hormones GLP-1 and GIP after exposure to dexametha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GIP (glucose-dependent insulinotropic polypeptide)
  • GLP-1 (glucagon-like peptide-1)

Snippet

Sponsor: Hvidovre University Hospital | Conditions: Type 2 Diabetes | NA | Status: COMPLETED